Fig. 1
From: Emerging strategies in BRCA-positive pancreatic cancer
Treatment algorithm for pancreatic ductal adenocarcinoma (PDAC) patients. BRCA1 or 2 mutation determines the optimal therapy
Fig. 1 | Journal of Cancer Research and Clinical Oncology